Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Biomaterials for Local, Controlled Drug Delivery to the Injured Spinal Cord

Biomaterials for Local, Controlled Drug Delivery to the Injured Spinal Cord

Frontiers in Pharmacology, 2017 · DOI: 10.3389/fphar.2017.00245 · Published: May 10, 2017

Spinal Cord InjuryNeurologyBiomedical

Simple Explanation

Spinal cord injury (SCI) is a devastating condition leading to permanent paralysis. Current drug treatments are limited because they often don't reach the injury site effectively or for long enough. This review explores using biomaterials to deliver drugs directly to the injured spinal cord. These materials, like hydrogels and fibers, can release drugs in a controlled manner over time. By carefully choosing biomaterials and drug release strategies, we can better target the complex physiological changes that occur after SCI, potentially leading to improved regeneration and recovery.

Study Duration
Not specified
Participants
Not specified
Evidence Level
Review

Key Findings

  • 1
    Hydrogels, particles, and fibers/conduits are commonly used biomaterials for CNS drug delivery, providing a matrix for tissue restoration and tunable drug release.
  • 2
    Hydrogels are advantageous for their injectability and ability to fill irregular injury geometries, while particles allow for more sustained and controlled drug release.
  • 3
    Fibers and conduits offer anisotropic guidance cues for white matter tract regeneration, but their rigidity can be a limitation in contusive injuries.

Research Summary

This review discusses the limitations of current pharmacological treatments for SCI and highlights the potential of biomaterials for local, controlled drug delivery to address these limitations. Various biomaterials, including hydrogels, particles, and fibers/conduits, are explored for their ability to provide sustained drug release and physical guidance for tissue regeneration in the injured spinal cord. The review emphasizes the importance of considering the SCI pathophysiology timeline when selecting biomaterials and drug release strategies to optimize treatment efficacy and promote better regeneration and recovery.

Practical Implications

Localized Drug Delivery

Biomaterials can deliver drugs directly to the site of spinal cord injury, reducing side effects associated with systemic administration.

Controlled Release

Biomaterials can be engineered to release drugs over extended periods, matching the timeline of SCI pathophysiology.

Enhanced Regeneration

Biomaterials can provide physical support and guidance cues to promote axonal regeneration and functional recovery after SCI.

Study Limitations

  • 1
    Hydrogels often lack guidance features for white matter tract regeneration.
  • 2
    Fibers are generally more rigid than native spinal cord tissue.
  • 3
    Many hydrogels release drug quickly due to their highly porous network.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury